Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
ACS ES&T Water|April 18, 2024
Mitigating Contaminant-Driven Risks for the Safe Expansion of the Agricultural-Sanitation Circular Economy in an Urbanizing WorldLaura J Carter, Sarah Dennis, Katie Allen, et al.Aging & Mental Health|February 22, 2019
Do people with dementia and mild cognitive impairments experience stigma? A cross-cultural investigation between Italy, Poland and the UKKatarzyna Małgorzata Lion, Dorota Szcześniak, Katarzyna Bulińska, et al.Hepatology (Baltimore, Md.)|October 23, 2016
Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trialEric Lawitz, Fred Poordad, Julio A Gutierrez, et al.Journal of Global Health|March 3, 2018
Carrying water may be a major contributor to disability from musculoskeletal disorders in low income countries: a cross-sectional survey in South Africa, Ghana and VietnamJo-Anne Geere, Jamie Bartram, Laura Bates, et al.Lancet (London, England)|June 8, 2023
Burden of disease attributable to unsafe drinking water, sanitation, and hygiene in domestic settings: a global analysis for selected adverse health outcomesJennyfer Wolf, Richard B Johnston, Argaw Ambelu, et al.AIDS (London, England)|March 6, 2026
Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosingCraig W Hendrix, Sharon L Hillier, Linda-Gail Bekker, et al.The Journal of Infectious Diseases|May 6, 2025
Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: a Phase 2a Study in Participants at Low Risk for Acquiring HIV-1Sharon L Hillier, Linda-Gail Bekker, Sharon A Riddler, et al.Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trialLai Wei, Ji Dong Jia, Zhong Ping Duan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2026
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 StudyRaphael J Landovitz, Yvett Pinedo, Federico Hinestrosa, et al.Pageof 4